SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+5.87%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$671M
AUM Growth
+$671M
(-4.5%)
Cap. Flow
-$75.2M
Cap. Flow
% of AUM
-11.21%
Top 10 Holdings %
Top 10 Hldgs %
36.87%
Holding
176
New
35
Increased
31
Reduced
45
Closed
50
Top Buys
| 1 |
Biogen
BIIB
|
$20.5M |
| 2 |
CELG
Celgene Corp
CELG
|
$10.4M |
| 3 |
CXRX
Concordia International Corp. Common Stock
CXRX
|
$9.03M |
| 4 |
BCOM
B Communications Ltd
BCOM
|
$6.45M |
| 5 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
$5.32M |
Top Sells
| 1 |
ENDP
Endo International plc
ENDP
|
$18.8M |
| 2 |
Perrigo
PRGO
|
$16.3M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$13.3M |
| 4 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$12.5M |
| 5 |
Amgen
AMGN
|
$9.21M |
Sector Composition
| 1 | Healthcare | 77.22% |
| 2 | Technology | 6.01% |
| 3 | Utilities | 2.06% |
| 4 | Industrials | 1.46% |
| 5 | Consumer Discretionary | 1.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BITI
51
DELISTED
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
| $3.93M | 0.39% | +196,800 | New | +$3.93M |
|
52
SPDR Euro Stoxx 50 ETF
FEZ
$4.54B
| $3.93M | 0.38% | 104,920 +10,920 | +12% | +$409K |
|
|
PTLA
53
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.92M | 0.38% | 86,000 -14,023 | -14% | -$639K |
|
|
MDVN
54
DELISTED
MEDIVATION, INC.
MDVN
| $3.9M | 0.38% | 34,115 -2,000 | -6% | -$228K |
|
|
FOMX
55
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $3.9M | 0.38% | 380,000 +180,000 | +90% | +$1.85M |
|
56
Assertio
ASRT
$80.4M
| $3.86M | 0.38% | 180,000 -20,000 | -10% | -$429K |
|
|
ALPN
57
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $3.86M | 0.38% | +255,000 | New | +$3.86M |
|
|
RCPT
58
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $3.8M | 0.37% | 20,000 +2,500 | +14% | +$475K |
|
|
VIRX
59
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $3.72M | 0.36% | 1,235,000 -65,000 | -5% | -$196K |
|
|
ATYR
60
aTyr Pharma
ATYR
$527M
| $3.7M | 0.36% | +209,027 | New | +$3.7M |
|
61
A.O. Smith
AOS
$9.99B
| $3.64M | 0.36% | 50,620 -10,980 | -18% | -$790K |
|
62
SPDR S&P Regional Banking ETF
KRE
$3.99B
| $3.54M | 0.35% | +80,080 | New | +$3.54M |
|
63
Dynavax Technologies
DVAX
$1.19B
| $3.51M | 0.34% | +150,000 | New | +$3.51M |
|
|
SAGE
64
DELISTED
Sage Therapeutics
SAGE
| $3.5M | 0.34% | 48,000 -17,724 | -27% | -$1.29M |
|
|
KITE
65
DELISTED
Kite Pharma, Inc.
KITE
| $3.47M | 0.34% | 56,970 -9,000 | -14% | -$549K |
|
|
MRNS
66
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $3.46M | 0.34% | 298,533 +85,000 | +40% | +$986K |
|
67
Arrowhead Research
ARWR
$3.05B
| $3.4M | 0.33% | +475,000 | New | +$3.4M |
|
68
Halozyme
HALO
$8.56B
| $3.39M | 0.33% | +150,000 | New | +$3.39M |
|
69
Ocular Therapeutix
OCUL
$2.12B
| $3.37M | 0.33% | +160,000 | New | +$3.37M |
|
|
PVLA
70
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $3.3M | 0.32% | +1,200,000 | New | +$3.3M |
|
|
RPTP
71
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $3.26M | 0.32% | +206,500 | New | +$3.26M |
|
72
TherapeuticsMD
TXMD
$12.8M
| $3.24M | 0.32% | 412,500 +47,500 | +13% | +$373K |
|
73
MacroGenics
MGNX
$112M
| $3.23M | 0.32% | 85,000 +25,000 | +42% | +$949K |
|
|
TRIL
74
DELISTED
Trillium Therapeutics Inc.
TRIL
| $3.21M | 0.31% | 147,000 +52,000 | +55% | +$1.13M |
|
75
PTC Therapeutics
PTCT
$3.92B
| $3.2M | 0.31% | 66,500 -3,500 | -5% | -$168K |
|